Godrej Agrovet Limited has informed the Exchange about Transcript
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godrej Agrovet reported its highest-ever standalone profitability in FY'25, with consolidated EBITDA margin (excluding one-time items) improving 110 basis points despite flat year-on-year revenue. Animal Feed segment margin expanded sharply from 4.6% to 6.1%, with EBIT per metric ton rising 28% to INR1,973. The Crop Protection business delivered a 40% segment margin, though management flagged this as unsustainable and guided for 30%+ going forward. Management guided for 16-18% top-line and bottom-line growth in FY'26, driven by volume growth in Crop Protection, recovery in Aqua Feed, and a turnaround in the loss-making Astec LifeSciences (losses expected to halve). The company also announced plans to acquire 100% of Godrej Tyson Foods (CDPL) within a month to enable portfolio restructuring, with a 35% growth target set for the Astec CDMO business over the next couple of years.
The detailed FY'26 guidance covering 16-18% growth in both revenue and profit, along with a clear Astec turnaround plan and potential portfolio reorganization, should be viewed positively by investors. The acquisition of full ownership in the poultry JV provides flexibility for future value unlocking, though Crop Protection margin normalisation from 40% to ~30% signals some earnings reset ahead.